Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia

Kristina Dietert1, Birgitt Gutbier2, Sandra M Wienhold2

  • 1Department of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.

Plos One
|November 21, 2017
PubMed

Insights

Histopathology is crucial for evaluating mouse pneumonia models. This study details distinct features across various bacterial and viral pneumonia models, enabling standardized scoring for better treatment validation.

Area of Science:

  • Pathology
  • Infectious Diseases
  • Animal Models

Background:

  • Pneumonia is a leading infectious cause of death globally.
  • Murine models are vital for studying pneumonia and testing treatments.
  • Histopathology is the gold standard for evaluating pneumonia in mouse models.

Purpose of the Study:

  • To systematically describe and compare histopathological features of diverse acute pneumonia mouse models.
  • To identify criteria for semiquantitative scoring systems tailored to specific pathogens and models.
  • To highlight factors influencing experimental pneumonia pathology.

Main Methods:

  • Induction of acute pneumonia in mice using various pathogens: Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Legionella pneumophila, Escherichia coli, MERS-CoV, and Influenza A virus (IAV).
  • Histopathological analysis and comparison of distinct features across models.
  • Identification of pathogen- and model-specific patterns for scoring criteria development.

Main Results:

  • Striking differences observed in lesion distribution, pneumonia characteristics, inflammatory cell types, adjacent tissue lesions, and pathogen detectability.
  • Core criteria identified for semiquantitative scoring systems, considering pathogen- and model-specific pneumonia patterns.
  • Pathogen- and model-specific criteria are necessary for accurate quantification and comparison of experimental outcomes.

Conclusions:

  • Histopathological evaluation of mouse pneumonia models requires pathogen- and model-adapted criteria for accurate assessment.
  • Standardized validation and comparison of preclinical treatment strategies are facilitated by these criteria.
  • Understanding model-specific pathologies is essential for advancing pneumonia research and therapeutic development.

Related Concept Videos